Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | ALDH1A3 | P47895 | 8/20 | 0.36 |
| ▸ | ALDH1A2 | O94788 | 7/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL248654 | 0.78 | GSK3A (0.47) | PGRALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL14877423 | 0.76 | GSK3A (0.44) | PGRALDH1A1KMT2AMEN1USP2 | |
| SCHEMBL10751885 | 0.73 | MAPK14 (0.50) | ALDH1A1LMNAMAPTHSD17B10KMT2A | |
| SCHEMBL20720005 | 0.72 | SMN1; SMN2 (0.41) | PGRALDH1A1LMNAMAPTHSD17B10 | |
| SCHEMBL16021998 | 0.70 | ALDH1A1 (0.54) | ALDH1A1MAPTHSD17B10KMT2AMEN1 | |
| SCHEMBL17222514 | 0.68 | POLB (0.51) | ALDH1A1LMNAMAPTKMT2AMEN1 | |
| SCHEMBL17427482 | 0.68 | TYRO3 (0.38) | PGRALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL10755351 | 0.67 | POLB (0.46) | ALDH1A1LMNAMAPTKMT2AMEN1 | |
| SCHEMBL18816329 | 0.67 | KDR (0.30) | — | |
| SCHEMBL28879227 | 0.67 | GSK3A (0.52) | PGRALDH1A1GSK3AGSK3BALDH1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9573909-B2 | 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides | FMC CORPORATION (US) | 2017-02-21 | — | — | US | disclosed |
| US-20150203457-A1 | 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2015-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203457-A1 | 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES | DDT, AADAC, DAZAP1 | PGR 4679/4885ALDH1A1 144/4885LMNA 4620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.